Skip to main content
Login
User menu
Mega menu
EASL
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Policy Dialogues
EASL Quiz
ePosters
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - International Liver Congress
Industry Symposia - Liver Cancer Summit
Industry Symposia - NAFLD Summit 2022
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
EASL Studio Podcast S3 E13: Next-generation metrics for science beyond journal impact factor and citations: The role of social media
November 30, 2022
EASL Policy Dialogues Episode 4: Fatty liver disease: The approaching tsunami in NCDs
November 25, 2022
EASL Studio S3 E12: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within
November 23, 2022
EASL Studio Podcast S3 E12: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within
November 23, 2022
EASL Studio S3 E11: Regenerative Hepatology: From stem cells to tissue engineering
November 16, 2022
EASL Studio Podcast S3 E11: Regenerative Hepatology: From stem cells to tissue engineering
November 16, 2022
EASL Studio Podcast S3 E10: Cholestatic pruritus: Can the itch be ditched?
November 9, 2022
EASL Studio S3 E10: Cholestatic pruritus: Can the itch be ditched?
November 9, 2022
EASL Studio S3 E9: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?
November 2, 2022
EASL Studio Podcast S3 E9: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?
November 2, 2022
EASL Studio Podcast S3 E8: Transplanting patients with cancer – Is there a limit?
October 26, 2022
EASL Studio S3 E8: Transplanting patients with cancer – Is there a limit?
October 26, 2022
EASL Studio S3 Special Edition: Ending fatty liver disease as a public health threat
October 25, 2022
EASL Studio Podcast S3 Special Edition: Ending fatty liver disease as a public health threat
October 25, 2022
EASL Studio S3 E7: Bugs and the liver — The role of the gut microbiome in liver diseases
October 19, 2022
EASL Studio Podcast S3 E7: Bugs and the liver — The role of the gut microbiome in liver diseases
October 19, 2022
EASL Studio S3 E6: How to improve end-of-life care in liver disease?
October 12, 2022
EASL Studio Podcast S3 E6: How to improve end-of-life care in liver disease?
October 12, 2022
EASL Studio S3 E5: JHEP Live: Stigma and alcohol
October 5, 2022
EASL Studio Podcast S3 E5: JHEP Live: Stigma and alcohol
October 5, 2022
Pagination
First page
« First
Previous page
‹‹
…
Page
3
Page
4
Page
5
Page
6
Current page
7
Page
8
Page
9
Page
10
Page
11
Next page
››
Last page
Last »
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy